XML 32 R102.htm IDEA: XBRL DOCUMENT v3.20.1
Note 23 - Subsequent Events (Details Textual) - USD ($)
1 Months Ended
Mar. 20, 2020
Mar. 18, 2020
Sep. 30, 2017
Mar. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Loans Payable, Noncurrent, Total       $ 4,551,000 $ 4,608,000
O-Bank Co., Ltd. [Member] | Nonrevolving Credit Facility [Member]            
Line of Credit Facility, Maximum Borrowing Capacity $ 5,000,000          
Debt Instrument, Term (Month) 2 years          
O-Bank Co., Ltd. [Member] | Nonrevolving Credit Facility [Member] | Taipei Interbank Offer Rate (TAIBOR) [Member]            
Debt Instrument, Basis Spread on Variable Rate 1.17%          
O-Bank Co., Ltd. [Member] | Revolving Credit Facility [Member]            
Loans Payable, Noncurrent, Total       $ 4,600,000 $ 4,600,000  
O-Bank Co., Ltd. [Member] | Revolving Credit Facility [Member] | Taipei Interbank Offer Rate (TAIBOR) [Member]            
Debt Instrument, Basis Spread on Variable Rate     0.91%      
Subsequent Event [Member] | O-Bank Co., Ltd. [Member] | Nonrevolving Credit Facility [Member]            
Line of Credit Facility, Maximum Borrowing Capacity $ 5,000,000          
Debt Instrument, Term (Month) 2 years          
Subsequent Event [Member] | O-Bank Co., Ltd. [Member] | Nonrevolving Credit Facility [Member] | Taipei Interbank Offer Rate (TAIBOR) [Member]            
Debt Instrument, Basis Spread on Variable Rate 1.17%          
AEROSURF Funding Term Sheet [Member] | Subsequent Event [Member] | Lee’s Pharmaceutical Holdings Limited [Member]            
Nonrefundable Payments, Tranche One   $ 1,000,000        
Nonrefundable Payments, Tranche Two   1,400,000        
Nonrefundable Payments, Tranche Three   1,500,000        
Nonrefundable Payments, Last Payment, Subject to Adjustment   400,000        
Minimum Proceeds from Sale of Equity Securities   $ 4,500,000        
Percentage of Amount Funded for Development, Repaid   125.00%        
Percentage of Revenue, Pay to Counter Party   50.00%